GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bespoke Extracts Inc (OTCPK:BSPK) » Definitions » Net Current Asset Value

Bespoke Extracts (Bespoke Extracts) Net Current Asset Value : $-0.20 (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Bespoke Extracts Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

Bespoke Extracts's net current asset value per share for the quarter that ended in Dec. 2023 was $-0.20.

The historical rank and industry rank for Bespoke Extracts's Net Current Asset Value or its related term are showing as below:

During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of Bespoke Extracts was 16.62. The lowest was 5.92. And the median was 11.27.

BSPK's Price-to-Net-Current-Asset-Value is not ranked *
in the Drug Manufacturers industry.
Industry Median: 5.475
* Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.

Bespoke Extracts Net Current Asset Value Historical Data

The historical data trend for Bespoke Extracts's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bespoke Extracts Net Current Asset Value Chart

Bespoke Extracts Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Dec22 Dec23
Net Current Asset Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.04 -0.13 -0.08 -0.10 -0.20

Bespoke Extracts Quarterly Data
Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.10 -0.13 -0.16 -0.18 -0.20

Competitive Comparison of Bespoke Extracts's Net Current Asset Value

For the Drug Manufacturers - Specialty & Generic subindustry, Bespoke Extracts's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bespoke Extracts's Price-to-Net-Current-Asset-Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bespoke Extracts's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where Bespoke Extracts's Price-to-Net-Current-Asset-Value falls into.



Bespoke Extracts Net Current Asset Value Calculation

Bespoke Extracts's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Dec. 2023 is calculated as

Net Current Asset Value Per Share(A: Dec. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(0.082-2.079-0-0)/10.1685
=-0.20

Bespoke Extracts's Net Current Asset Value (NCAV) per share for the quarter that ended in Dec. 2023 is calculated as

Net Current Asset Value Per Share(Q: Dec. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(0.082-2.079-0-0)/10.1685
=-0.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bespoke Extracts  (OTCPK:BSPK) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


Bespoke Extracts Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of Bespoke Extracts's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Bespoke Extracts (Bespoke Extracts) Business Description

Traded in Other Exchanges
N/A
Address
12001 E. 33rd Avenue, Unit O, Aurora, Denver, CO, USA, 80010
Bespoke Extracts Inc is focused on selling its proprietary line of specially-formulated, premium quality, hemp-derived CBD products. It unveiled a new brand image and a new line-up of seven hemp-derived CBD formulations available for purchase in the form of tinctures and softgels.
Executives
Michael Feinsod director, 10 percent owner, officer: CEO
Tyler Hunter Garth director, officer: President 6300 E HAMPDEN AVE, 2306, DENVER CO 80222
Danil Pollack 10 percent owner, officer: President and CEO 6 GAUGUIN AVE., VAUGHAN A6 L4J9J7
Niquana Monique Noel 10 percent owner, officer: President and CEO 1316 SW 3RD COURT, FT. LAUDERDALE FL 33312
Marc Yahr director, 10 percent owner, officer: President and CEO 1966 NE 123RD STREET, NUM 170, NORTH MIAMI FL 33181
Anthony Ivankovich 10 percent owner 971 CRANDON BLVD., APT. PH-6, KEY BISCAYNE FL 33149
Mcglothlin Holdings, Ltd. 10 percent owner 402 W. DAVIS, LULING TX 78648
Barry Tenzer director, 10 percent owner, officer: President, CEO, CFO 290 LENOX AVENUE, NEW YORK NY 10027
Roberto Fata director, 10 percent owner, officer: Executive VP 290 LENOX AVENUE, SECOND FLOOR, NEW YORK NY 10027
Lyle Hauser 10 percent owner 290 LENOX AVENUE, SECOND FLOOR, NEW YORK NY 10027